The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

NCT02658175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Chylomicronemia Syndrome
Lipoprotein Lipase Deficiency
Hyperlipoproteinemia Type 1

Interventions

DRUG: Volanesorsen

Sponsor

Akcea Therapeutics

Collaborators

[object Object]